NASDAQ: GALTGalectin Therapeutics Inc Stock Ownership - Who owns Galectin Therapeutics?
Insider buying vs selling
Have Galectin Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Joel Lewis | President and CEO | 2025-03-03 | 56,420 | $1.57 | $88.58kSell |
| Richard E. Uihlein | Director | 2025-01-23 | 32,520 | $1.23 | $40.00kBuy |
| Harold H. Shlevin | Director | 2024-12-30 | 6,500 | $1.16 | $7.54kBuy |
| Kevin D. Freeman | Director | 2024-12-24 | 10,000 | $0.81 | $8.13kBuy |
| Richard A. Zordani Jr. | Director | 2024-12-24 | 10,000 | $0.82 | $8.16kBuy |
| Kary Eldred | Director | 2024-12-24 | 13,469 | $0.82 | $11.04kBuy |
| Khurram Jamil | Chief Medical Officer | 2024-12-23 | 13,654 | $0.88 | $12.04kSell |
| Jack W. Callicutt | Chief Financial Officer | 2024-12-23 | 40,000 | $0.89 | $35.48kSell |
| Joel Lewis | President and CEO | 2024-12-23 | 56,000 | $0.89 | $49.62kSell |
| Kary Eldred | Director | 2024-10-23 | 500 | $2.60 | $1.30kBuy |
GALT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GALT insiders and whales buy or sell their stock.
GALT Shareholders
What type of owners hold Galectin Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| 10x Fund LP | 40.76% | 25,751,845 | $35.54M | Insider |
| James C. Czirr | 32.82% | 20,732,982 | $28.61M | Insider |
| Rod D. Martin | 19.08% | 12,057,197 | $16.64M | Insider |
| Richard E. Uihlein | 16.35% | 10,328,981 | $14.25M | Insider |
| David Platt | 13.32% | 8,418,743 | $11.62M | Insider |
| Vanguard Group Inc | 3.38% | 2,137,603 | $2.95M | Institution |
| Blackrock Inc | 2.61% | 1,651,891 | $2.28M | Institution |
| Osaic Holdings Inc | 1.87% | 1,182,095 | $1.63M | Institution |
| Geode Capital Management LLC | 1.38% | 870,589 | $1.20M | Institution |
| Joel Lewis | 1.32% | 836,592 | $1.15M | Insider |
GALT vs Biotech Stocks
Galectin Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.